You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Dow
Harvard Business School
Merck
Moodys

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Litigation Details for Focus Products Group International, LLC v. Kartri Sales Company, Inc. (S.D.N.Y. 2015)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Focus Products Group International, LLC v. Kartri Sales Company, Inc. (S.D.N.Y. 2015)

Docket   Start Trial Date Filed 2015-12-30
Court District Court, S.D. New York Date Terminated
Cause 28:1338pt Patent Infringement Assigned To Paul Adam Engelmayer
Jury Demand Both Referred To
Parties FOCUS PRODUCTS GROUP INTERNATIONAL, LLC; HOOKLESS SYSTEMS OF NORTH AMERICA, INC.; KARTRI SALES COMPANY, INC.; MARQUIS MILLS, INTERNATIONAL, INC.; SF HOME DECOR, LLC; SURE FIT HOME DECOR HOLDINGS CORP.; SURE FIT HOME PRODUCTS, LLC; ZAHNER DESIGN GROUP, LTD.
Patents 7,863,297; 8,609,863; 8,956,651
Attorneys Bernhard Percival Molldrem , Jr.; Donald J. Cox , Jr.; Edward Thomas La Barr; Lee A. Goldberg; Limor Wigder; Morris E. Cohen; Ryan W O'Donnell
Firms Edward Thomas La Barr; Goldberg Cohen LLP; Goldberg Cohen, LLP; Law Office of Bernhard Molldrem; Law Offices of Donald Cox LLC; Volpe & Koenig, P.C
Link to Docket External link to docket
Small Molecule Drugs cited in Focus Products Group International, LLC v. Kartri Sales Company, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .
Biologic Drugs cited in Focus Products Group International, LLC v. Kartri Sales Company, Inc.
The biologic drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Focus Products Group International, LLC v. Kartri Sales Company, Inc. (S.D.N.Y. 2015)

Date Filed Document No. Description Snippet Link To Document
2020-05-03 302 Order on Motion for Reconsideration April 16, 2020 summary judgment decision, Dkt. 297 (“MSJ Op.”). Dkt. 300 (“MTR”). For the following …609 and ’088 utility patents, is equally unavailing. As to these utility patents, defendants argue that…1992); King Cty. v. IKB Deutsche Industriebank AG, 863 F. Supp. 2d 317, 319–20 (S.D.N.Y. 2012). “A [m]otion…Court’s finding with regard to the ’248 utility patent. MTR at 2–5. Second, they challenge the Court’…s findings regarding the ’088 and ’609 utility patents. Id. at 5–6. Finally, they argue that ownership External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Johnson and Johnson
Express Scripts
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.